查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612896

細胞治療技術市場：按產品、製程、細胞類型和最終用戶分類 - 2025-2030 年全球預測

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年細胞治療技術市值為194.8億美元，預計到2024年將達到223.1億美元，複合年成長率為14.63%，到2030年將達到506.9億美元。

細胞治療技術包括利用活細胞治療或預防疾病的各種方法和生物技術。這些技術在腫瘤學、再生醫學和血液學等多個領域展現了前景，提供了特異性而有效的個人化治療選擇。對細胞療法的需求源自於其解決複雜醫療問題的潛力，特別是那些傳統治療方法無法解決的問題。開發應用範圍廣泛，最終用途範圍很大，包括正在積極開發和部署這些治療方法的生物技術公司、醫院、研究機構和學術實驗室。市場成長是由幹細胞研究的進步、合作夥伴數量的增加以及對研究和研究的大量投資所推動的。成長的主要促進因素包括慢性病的增加、資金籌措的增加以及加速臨床試驗和核准的有利監管環境。新的商機在於擴大 CAR-T 細胞的使用、增強基因編輯技術以及利用 3D 生物列印進行組織工程。公司可以透過投資創新夥伴關係關係、收購新興新興企業以及專注於生產擴充性來利用這些優勢。然而，市場限制仍然存在，包括高昂的營運成本、嚴格的法律規範以及圍繞基因改造和病人安全的倫理問題。這些挑戰凸顯了嚴格的臨床檢驗和強力的安全標準的必要性。此外，有限的生產能力和對專業醫療基礎設施的需求也阻礙了廣泛採用。需要創新的領域包括有針對性的輸送系統、提高細胞活力和穩定性，以及透過自動化和人工智慧驅動的流程降低製造成本。探索同種異體細胞療法，避免目前患者特異性（自體）細胞療法的局限性，可能會增加可及性和市場範圍。細胞治療市場的本質是動態的、競爭激烈且快速發展的，因此公司必須保持敏捷、不斷創新並有效應對監管環境以保持競爭力。

主要市場統計
基準年[2023] 194.8億美元
預測年份 [2024] 223.1億美元
預測年份 [2030] 506.9億美元
複合年成長率（%） 14.63%

市場動態：揭示快速發展的細胞治療技術市場的關鍵市場洞察

供需的動態交互作用正在改變細胞治療技術市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病和感染疾病的增加
    • 增加細胞療法生產設施的 GMP 認證
    • 透過投資細胞研究擴大政府舉措
  • 市場限制因素
    • 與細胞治療技術相關的高成本
  • 市場機會
    • 持續關注個人化醫療
    • iPS 細胞作為替代 ESC 技術的出現
  • 市場挑戰
    • 缺乏熟練的專業人員和嚴格的法律規範

波特五力：駕馭細胞治療技術市場的策略工具

波特五力是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞治療技術市場的外部影響

外部宏觀環境因素在塑造細胞治療技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解細胞治療技術市場的競爭狀況

對細胞治療技術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質細胞治療技術市場供應商績效評估

FPNV定位矩陣是評估細胞治療技術市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定細胞治療技術市場成功之路的策略分析與建議

對於旨在加強在全球市場的影響力的公司來說，細胞治療技術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病和感染疾病的發生率正在增加
      • 增加細胞療法生產設施的 GMP 認證
      • 政府大力投資細胞研究
    • 抑制因素
      • 與細胞治療技術相關的高成本
    • 機會
      • 持續關注個人化醫療
      • iPSC 的出現作為 ES 細胞的技術替代品
    • 任務
      • 缺乏熟練的專業人員和嚴格的法規結構
  • 市場區隔分析
    • 產品：巨量資料分析工具的出現將推動細胞治療軟體工具的採用
    • 過程：細胞保存技術的進步
    • 細胞類型：人類細胞在細胞和基因治療中的使用越來越多
    • 最終用戶：政府鼓勵對研究機構投資的舉措
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞治療技術市場：依產品

  • 消耗品
  • 裝置
    • 細胞處理設備
    • 免洗設備
  • 軟體

第7章細胞治療技術市場：依製程分類

  • 細胞儲存、分配和處理
  • 細胞處理
  • 過程監控和品管

第8章按細胞類型分類的細胞治療技術市場

  • 動物細胞
  • 人體細胞
    • 分化細胞
    • 幹細胞

第9章細胞治療技術市場：依最終用戶分類

  • 醫療保健和生命科學
  • 調查機構

第10章美洲細胞治療技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞治療技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲細胞治療技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Clade Therapeutics 宣布收購 Gadeta BV
    • 投資者投資細胞療法生產，Start-UpsCerales 增資 2.55 億美元
    • NewBiologix 籌集了 5000 萬美元，用於推進基因和細胞療法製造的新技術平台
  • 戰略分析和建議

公司名單

  • Anterogen Co., Ltd.
  • Atara Biotherapeutics by FUJIFILM Corporation
  • Athersys, Inc.
  • Becton, Dickinson and Company
  • Bluebird Bio, Inc.
  • Bristol-Myers Squibb Company
  • Cellectis SA
  • Danaher Corporation
  • ElevateBio
  • Gamida Cell
  • GE Healthcare
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • Novartis AG
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Takeda Pharmaceutical Company Limited
  • Tego Science
  • Terumo Bct, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation
Product Code: MRR-034230D3E636

The Cell Therapy Technologies Market was valued at USD 19.48 billion in 2023, expected to reach USD 22.31 billion in 2024, and is projected to grow at a CAGR of 14.63%, to USD 50.69 billion by 2030.

Cell therapy technologies encompass a diverse range of methodologies and biotechnologies that harness living cells to treat or prevent diseases. These technologies hold promise across various domains such as oncology, regenerative medicine, and hematology, offering personalized treatment options that are both specific and effective. The necessity of cell therapy stems from its potential to address complex medical challenges, especially those unmet by traditional treatments. Applications are wide-ranging, with significant end-use scope in biotechnology firms, hospitals, research institutes, and academic labs actively developing and deploying these therapies. Market growth is bolstered by advancements in stem cell research, increasing partnership collaborations, and substantial investment inflows directed toward R&D. Key growth influencers include the rising prevalence of chronic diseases, increased funding, and favorable regulatory scenarios that accelerate clinical trials and approvals. Emerging opportunities lie in expanding the use of CAR-T cells, enhancing gene editing technologies, and leveraging 3D bioprinting for tissue engineering. Firms can capitalize on these by investing in innovative partnerships, acquiring emerging startups, and focusing on scalability of production. However, market limitations exist, such as high operational costs, stringent regulatory frameworks, and ethical concerns surrounding genetic modifications and patient safety. These challenges underscore the necessity for rigorous clinical validation and robust safety standards. Further, limited production capabilities and the need for specialized healthcare infrastructure can impede wide-scale adoption. Areas ripe for innovation include targeted delivery systems, improving cell viability and stability, and reducing manufacturing costs through automation and AI-driven processes. Research into allogenic cell therapy that circumvents current limitations of patient-specific (autologous) cell therapies could enhance accessibility and market reach. The nature of the cell therapy market is dynamic, with high competition and rapid technological evolution, emphasizing the importance for companies to remain agile, continuously innovate, and navigate regulatory landscapes effectively to maintain a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 19.48 billion
Estimated Year [2024] USD 22.31 billion
Forecast Year [2030] USD 50.69 billion
CAGR (%) 14.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Therapy Technologies Market

The Cell Therapy Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic diseases and infections globally
    • Rising GMP certifications for cell therapy production facilities
    • Surge in government initiatives through investments in cell-based research
  • Market Restraints
    • High costs associated with cell therapy technologies
  • Market Opportunities
    • Ongoing focus on personalized medicine
    • Emergence of iPSCs as an alternative to ESCs in technologies
  • Market Challenges
    • Dearth of skilled professionals and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Cell Therapy Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Therapy Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Therapy Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Therapy Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Therapy Technologies Market

A detailed market share analysis in the Cell Therapy Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Therapy Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Therapy Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Therapy Technologies Market

A strategic analysis of the Cell Therapy Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Equipment, and Software. The Equipment is further studied across Cell Processing Equipment and Single-Use Equipment.
  • Based on Process, market is studied across Cell Preservation, Distribution, & Handling, Cell Processing, and Process Monitoring & Quality Control.
  • Based on Cell Type, market is studied across Animal Cells and Human Cells. The Human Cells is further studied across Differentiated Cells and Stem Cells.
  • Based on End-User, market is studied across Healthcare & Life Science and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases and infections globally
      • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
      • 5.1.1.3. Surge in government initiatives through investments in cell-based research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cell therapy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing focus on personalized medicine
      • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
    • 5.2.2. Process: Advancements in cell preservation technologies
    • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
    • 5.2.4. End user: Government initiatives to propel investments in research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Therapy Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
    • 6.3.1. Cell Processing Equipment
    • 6.3.2. Single-Use Equipment
  • 6.4. Software

7. Cell Therapy Technologies Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Preservation, Distribution, & Handling
  • 7.3. Cell Processing
  • 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

  • 8.1. Introduction
  • 8.2. Animal Cells
  • 8.3. Human Cells
    • 8.3.1. Differentiated Cells
    • 8.3.2. Stem Cells

9. Cell Therapy Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare & Life Science
  • 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
    • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
    • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anterogen Co., Ltd.
  • 2. Atara Biotherapeutics by FUJIFILM Corporation
  • 3. Athersys, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bluebird Bio, Inc.
  • 6. Bristol-Myers Squibb Company
  • 7. Cellectis SA
  • 8. Danaher Corporation
  • 9. ElevateBio
  • 10. Gamida Cell
  • 11. GE Healthcare
  • 12. Gilead Sciences, Inc.
  • 13. JCR Pharmaceuticals Co., Ltd.
  • 14. Johnson & Johnson Services, Inc.
  • 15. Lonza Group Ltd.
  • 16. Merck KGaA
  • 17. Miltenyi Biotec B.V. & Co. KG
  • 18. Novartis AG
  • 19. Sartorius AG
  • 20. STEMCELL Technologies Inc.
  • 21. Takeda Pharmaceutical Company Limited
  • 22. Tego Science
  • 23. Terumo Bct, Inc.
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Vericel Corporation

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023